Serum trans-lycopene

Table 2.8.a. Serum trans-lycopene: Total population

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
size

10th

50th

90th

Males and Females

Total, 3 years and older

20.5

(19.8-21.1)

10.5

(10.0-11.0)

22.0

(21.2-22.8)

37.5

(36.1-38.6)

8348

3–5 years

16.1

(15.2-17.1)

7.90

(7.30-8.90)

17.4

(16.2-18.1)

30.7

(28.5-32.8)

427

6–11 years

21.6

(20.7-22.5)

11.4

(10.4-12.7)

22.7

(21.4-23.7)

36.0

(35.0-37.2)

1012

12–19 years

21.6

(21.1-22.1)

12.8

(11.9-13.6)

22.3

(21.8-22.8)

36.1

(35.1-37.5)

2205

20–39 years

22.7

(21.5-23.9)

12.5

(11.7-13.8)

23.7

(22.5-24.8)

39.1

(37.6-41.0)

1714

40–59 years

21.1

(20.1-22.1)

10.7

(9.80-11.7)

22.6

(21.3-24.1)

38.1

(36.6-39.8)

1468

60 years and older

15.4

(14.6-16.3)

6.70

(5.70-7.30)

17.1

(15.9-17.9)

33.4

(31.5-34.5)

1522

Males

Total, 3 years and older

21.2

(20.5-22.0)

10.8

(10.3-11.3)

23.1

(22.2-24.0)

39.0

(37.4-40.6)

4048

3–5 years

16.0

(14.9-17.2)

7.80

(7.10-9.00)

17.7

(16.0-19.1)

28.4

(27.1-30.9)

216

6–11 years

21.7

(20.4-23.1)

11.5

(9.40-13.3)

23.0

(21.2-25.0)

36.4

(34.1-40.1)

507

12–19 years

22.5

(21.8-23.2)

13.4

(12.4-14.0)

23.5

(22.5-24.5)

37.5

(35.3-39.8)

1091

20–39 years

24.2

(22.6-25.9)

13.8

(11.7-15.0)

25.0

(23.6-26.3)

42.1

(39.1-45.2)

724

40–59 years

21.7

(20.4-23.2)

11.1

(9.20-11.9)

23.7

(21.9-25.5)

39.8

(37.5-41.7)

761

60 years and older

15.2

(14.1-16.4)

6.30

(5.60-7.50)

16.8

(15.5-17.9)

33.2

(30.5-36.0)

749

Females

Total, 3 years and older

19.7

(19.1-20.4)

10.3

(9.70-10.9)

21.1

(20.1-21.9)

35.6

(34.3-36.7)

4300

3–5 years

16.2

(14.6-18.1)

8.00

(6.20-10.3)

16.6

(14.9-18.6)

32.5

(29.1-34.3)

211

6–11 years

21.5

(20.6-22.4)

10.7

(9.70-13.0)

22.2

(20.6-23.3)

35.5

(34.1-37.3)

505

12–19 years

20.6

(20.0-21.3)

12.3

(11.5-13.1)

21.4

(20.0-22.2)

34.8

(32.1-36.3)

1114

20–39 years

21.3

(20.2-22.5)

12.2

(10.5-13.6)

22.3

(21.2-23.6)

36.7

(33.8-39.3)

990

40–59 years

20.4

(19.4-21.4)

10.7

(9.30-12.1)

21.8

(20.9-22.8)

36.5

(34.4-37.8)

707

60 years and older

15.6

(14.5-16.9)

6.70

(5.60-7.50)

17.3

(15.7-18.6)

33.3

(30.6-34.5)

773

Table 2.8.b. Serum trans-lycopene: Mexican Americans

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
size

10th

50th

90th

Males and Females

Total, 3 years and older

19.7

(18.9-20.5)

10.6

(9.90-11.6)

20.6

(19.8-21.5)

34.6

(33.0-36.0)

2111

3–5 years

15.0

(12.9-17.4)

7.30

(5.80-9.20)

15.7

(12.5-19.4)

30.4

(23.0-39.8)

124

6–11 years

19.7

(18.3-21.3)

10.5

(9.20-13.1)

20.5

(18.7-22.5)

33.7

(29.6-36.1)

289

12–19 years

20.4

(19.4-21.4)

12.3

(11.2-13.4)

20.7

(19.6-22.0)

32.9

(30.4-36.2)

696

20–39 years

21.4

(20.1-22.8)

12.1

(11.2-13.6)

21.7

(20.6-22.5)

36.0

(33.1-39.9)

460

40–59 years

19.1

(17.5-20.9)

10.2

(8.70-11.3)

20.0

(17.9-22.3)

34.4

(29.9-39.1)

287

60 years and older

13.9

(11.7-16.6)

6.20

(2.20-9.60)

15.3

(13.1-17.7)

30.1

(26.6-31.6)

255

Males

Total, 3 years and older

20.4

(19.6-21.2)

11.4

(10.2-12.0)

21.3

(20.6-21.9)

35.9

(32.7-39.4)

1018

3–5 years

15.2

(13.3-17.2)

8.60†

(1.80-11.3)

15.7

(12.4-18.1)

28.5†

(23.8-33.3)

62

6–11 years

20.8

(18.5-23.4)

12.6

(8.70-14.7)

20.6

(19.2-24.1)

33.4

(28.4-45.7)

140

12–19 years

21.1

(20.2-22.0)

12.9

(11.6-13.9)

21.5

(20.4-22.6)

34.6

(30.3-39.4)

330

20–39 years

22.0

(20.7-23.5)

12.4

(11.2-14.1)

22.2

(20.7-23.6)

39.1

(33.0-43.7)

213

40–59 years

20.0

(17.9-22.3)

10.2

(8.90-11.8)

20.9

(16.8-24.5)

35.5

(30.2-43.3)

147

60 years and older

13.0

(10.4-16.3)

5.20

(.800-7.50)

14.2

(10.6-17.7)

27.8

(24.0-31.4)

126

Females

Total, 3 years and older

19.0

(18.0-20.0)

10.2

(9.10-11.3)

20.0

(18.6-21.4)

33.7

(31.6-34.9)

1093

3–5 years

14.8

(11.0-19.8)

6.70†

(4.30-9.50)

15.0

(9.50-22.8)

32.7†

(20.3-37.9)

62

6–11 years

18.7

(16.8-20.7)

9.90

(9.10-11.0)

20.0

(16.9-22.9)

33.2

(28.6-35.4)

149

12–19 years

19.6

(18.4-20.9)

11.7

(10.2-13.6)

19.8

(18.3-21.2)

31.7

(29.7-35.9)

366

20–39 years

20.6

(18.9-22.5)

11.6

(10.3-13.2)

21.3

(19.0-22.7)

34.8

(30.1-37.6)

247

40–59 years

18.2

(16.4-20.2)

9.10

(5.30-13.2)

19.3

(17.9-20.8)

30.5

(28.2-36.9)

140

60 years and older

14.7

(12.1-18.0)

6.80

(1.90-10.3)

15.8

(13.7-20.7)

30.5

(24.4-36.1)

129

† Estimate is subject to greater uncertainty due to small cell size.

Table 2.8.d. Serum trans-lycopene: Non-Hispanic whites

Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.

Geometric mean
(95% conf. interval)

Selected percentiles (95% conf. interval)

Sample
size

10th

50th

90th

Males and Females

Total, 3 years and older

20.7

(19.9-21.4)

10.8

(10.2-11.4)

22.1

(21.0-23.2)

37.6

(36.3-38.7)

3578

3–5 years

15.4

(14.0-17.0)

7.90

(6.20-9.30)

16.6

(14.8-17.9)

27.5

(25.3-31.2)

132

6–11 years

21.5

(20.2-22.9)

11.4

(9.70-13.2)

22.2

(20.6-23.6)

35.8

(33.3-37.8)

300

12–19 years

21.1

(20.5-21.8)

12.8

(11.5-13.8)

21.9

(20.8-22.6)

35.3

(34.0-36.8)

656

20–39 years

22.9

(21.3-24.6)

13.1

(11.7-14.2)

24.2

(22.8-25.7)

39.6

(37.7-42.1)

770

40–59 years

21.9

(20.7-23.1)

11.8

(10.3-13.4)

23.2

(21.3-24.9)

38.5

(36.8-40.0)

777

60 years and older

16.1

(15.2-17.0)

7.00

(6.20-7.70)

17.8

(16.4-18.6)

33.9

(31.7-35.9)

943

Males

Total, 3 years and older

21.4

(20.5-22.4)

11.0

(9.90-11.6)

23.5

(22.3-24.5)

39.5

(37.9-40.9)

1737

3–5 years

14.4

(12.6-16.5)

7.80†

(4.40-9.50)

16.4

(14.3-19.1)

27.4†

(24.7-30.9)

71

6–11 years

21.7

(19.9-23.6)

12.2

(9.40-14.1)

22.2

(20.3-25.2)

36.0

(32.0-40.1)

157

12–19 years

22.1

(21.2-23.1)

12.9

(11.5-14.0)

23.2

(21.4-24.6)

37.0

(34.3-40.2)

323

20–39 years

24.8

(22.4-27.3)

13.9

(11.1-16.6)

25.8

(23.9-28.9)

42.4

(38.8-45.6)

312

40–59 years

22.6

(21.0-24.2)

11.4

(9.20-13.5)

24.5

(22.4-26.9)

40.0

(37.9-42.9)

407

60 years and older

15.7

(14.6-17.0)

6.90

(5.80-7.70)

17.5

(15.7-18.6)

33.8

(30.6-37.6)

467

Females

Total, 3 years and older

19.9

(19.2-20.7)

10.6

(9.90-11.4)

21.1

(20.1-22.1)

35.4

(33.9-36.7)

1841

3–5 years

16.6

(14.7-18.8)

8.70†

(6.20-13.1)

16.6

(14.7-18.9)

26.8†

(22.8-31.8)

61

6–11 years

21.3

(19.8-22.9)

11.0

(9.40-13.8)

21.7

(20.0-23.7)

34.2

(32.5-38.0)

143

12–19 years

20.2

(19.4-21.0)

12.6

(11.0-13.9)

21.3

(19.4-22.2)

32.4

(28.9-35.8)

333

20–39 years

21.3

(19.8-23.0)

12.3

(9.40-14.3)

22.4

(20.9-24.1)

36.5

(33.1-39.6)

458

40–59 years

21.2

(20.2-22.3)

12.6

(10.7-13.7)

22.0

(20.7-23.5)

36.6

(34.0-37.8)

370

60 years and older

16.4

(15.1-17.7)

6.90

(5.70-8.40)

17.9

(15.9-19.0)

33.8

(31.4-36.1)

476

† Estimate is subject to greater uncertainty due to small cell size.